The authors of the present study had previously shown that high expression levels of DR5, caspase-8 or both proteins correlated with a poorer prognosis of patients with lymph node metastasis.[@R4] Elevated expression of caspase-8 correlated with a prolonged tumor response in patients who did not have lymph node spread. The present studies showed a strong correlation for FADD/Caspase 8/DR5 expression in metastatic and non-metastatic tumor cells. For non-metastatic tumors high FADD/caspase 8/DR5 levels correlated with survival whereas in metastatic tumors high FADD/Caspase 8/DR5 levels correlated with reduced survival. The question still remains as to how enhanced FADD signaling could promote tumor progression in this cancer type: no additional studies were performed in the present manuscript to examine possible changes in cell signaling, e.g., ERK, JNK, NFκB in these cells that could be correlated with altered FADD levels.

If elevated ERK, JNK, and NFκB signaling is present in FADD high tumor cells a number of rational drug treatments could be proposed to reduce the impact of FADD overexpression. For example, Velcade is a clinically relevant inhibitor of NFκB function and multiple MEK1/2 inhibitors are under advanced clinical development.[@R5] As such, it will be of interest to see in the future whether rationally based combination therapy trials will be proposed by these or other investigators for the treatment of this form of head and neck cancer.
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